๐”– Scriptorium
โœฆ   LIBER   โœฆ

๐Ÿ“

Hepatitis B: The Hunt for a Killer Virus

โœ Scribed by Baruch S. Blumberg


Publisher
Princeton University Press
Year
2018
Tongue
English
Leaves
264
Category
Library

โฌ‡  Acquire This Volume

No coin nor oath required. For personal study only.

โœฆ Synopsis


About 375 million people are infected with the hepatitis B virus. It has killed more people than AIDS and also causes millions of cases of liver cancer. The discovery of this deadly virus and the vaccine against it--a vaccine that is sharply decreasing the infection rate worldwide and is probably the first effective cancer vaccine--was one of the great triumphs of twentieth-century medicine. And it almost didn't happen.


With wit and insight, this scientific memoir and story of discovery describes how Baruch Blumberg and a team of researchers found a virus they were not looking for and created a vaccine for a disease they previously knew little about--work that took the author around the world and won him the Nobel Prize.


Blumberg and his collaborators were investigating relationships between gene distribution and disease susceptibility, research that was yielding interesting data but no real breakthroughs. Many viewed their work as more field trip than science. But, through decades of hard work and investigative twists and turns, their pursuit led to the hepatitis B antigen, the elusive virus itself, and, ultimately, the vaccine. As he takes the reader through the detective work that culminated in his incredible discovery, the author recounts with immediacy exciting moments in the lab and in the field--from a hair-raising flight to Africa to an unpleasant encounter with Alaskan sled dogs.


The hepatitis B story is more than a fascinating chronicle of a major discovery. What Blumberg followed to the virus was a trail of remarkable "accidents" that happen when scientists seek answers to interesting questions. Those events, combined with the investigator's determined persistence, resulted in studies that generated a pharmaceutical industry, have far-flung public-health applications, and saved millions of lives.

โœฆ Table of Contents


Contents
Acknowledgments
Introduction
Chapter 1. Differences in Response to Disease
Chapter 2. Oxford and the National Institutes of Health: Inherited Variation and Susceptibility to Disease
Chapter 3. Polymorphisms and Geography: Disease, Genetics, and Evolutionary Biology
Chapter 4. We Discover a New Polymorphism: The Ag System
Chapter 5. The Discovery of Australia Antigen
Chapter 6. What Is Australia Antigen?
Chapter 7. Identifying the Hepatitis B Virus
Chapter 8. The Control of Posttransfusion Hepatitis
Chapter 9. The Hepatitis B Vaccine
Chapter 10. Hepatitis B Virus and Cancer of the Liver
Chapter 11. What Is Now Known about HBV?
Chapter 12. Back to Polymorphisms and Inherited Susceptibility to Disease
Chapter 13. HBV and Its Connections: Current Research and the Future
Appendix 1. Scientists and Staff at Fox Chase Cancer Center Referred to in the Text
Appendix 2. Research on Hyaluronic Acid
Appendix 3. The National Institutes of Health and the Funding of Basic Medical Research
Appendix 4. Molecular Biology
Appendix 5. A Gazetteer of Selected Place-Names Used in the Text
Index


๐Ÿ“œ SIMILAR VOLUMES


Hepaptitis A virus
โœ Feinstone, Stephen M.; Gust, Ian D ๐Ÿ“‚ Library ๐Ÿ“… 1988 ๐Ÿ› CRC Press ๐ŸŒ English
Hepatitis B: The Virus, the Disease, and
โœ Toby K. Eisenstein (auth.), Irving Millman, Toby K. Eisenstein, Baruch S. Blumbe ๐Ÿ“‚ Library ๐Ÿ“… 1984 ๐Ÿ› Springer US ๐ŸŒ English

<p>Toby K. Eisenstein Symposium Committee Chairperson Temple University School of Medicine Philadelphia, Pennsylvania 19140 This symposium is the thirteenth biennial clinical microbiology program sponsored by the Eastern Pennsylvania Branch of the American Society for Microbiology in cooperation wit

Hepatitis B Virus Antigens in Tissues
โœ M. B. Ray MBBS, PhD (auth.) ๐Ÿ“‚ Library ๐Ÿ“… 1979 ๐Ÿ› Springer Netherlands ๐ŸŒ English

<p>Ever since the emergence of the concept of catharral jaundice by Virchow, viral hepatitis has eluded scientists as a pathogenetic enigma. A tremendous new impetus was given to hepatitis research by Baruch Blumberg's discovery of his 'Australia Antigen', now known as hepatitis B surface antigen. T